Aviva Systems Biology Acquires GenWay Biotech
SAN DIEGO, Feb. 23, 2017 /PRNewswire/ -- Aviva Systems Biology Corporation (ASB) which supplies protein research tools, announced the acquisition of GenWay Biotech Incorporated, a protein solutions and applications provider with a comprehensive service and product offering for both the research and diagnostic markets.
"This acquisition will facilitate growth and enhance capabilities for both entities. GenWay's 18 years of experience producing proteins, antibodies, and ELISA assays will nicely complement ASB's objective to become a leading provider of proteomic solutions," said Peter Jiang, M.D., ASB's Chief Executive Officer. "We see opportunities to expand both ASB's and GenWay's existing businesses as a result from this acquisition."
"We expect a smooth transition for both companies and their respective customers," said Matt Landry, ASB's Vice President of Marketing and Sales. Prior to joining ASB in 2010, Mr. Landry was the Senior Vice President of Marketing and Sales for GenWay Biotech. He played a critical role in leading GenWay's product and service divisions from 2004 to 2010.
GenWay Biotech maintains ISO13485 accreditation for the development, validation, and production of antibodies and proteins for use in FDA regulated or CE marked products. The company also offers clinical laboratory services in a CAP accredited, CLIA facility. The company's services and products are offered to customers in research, diagnostic, and government institutions. This transaction will uniquely position ASB as a leader in product development, production, and services to assist customers with their research and diagnostic needs.
About Aviva Systems Biology
Aviva Systems Biology Corporation is a leader in antibody manufacturing. The company aims to enable life science research discoveries by developing novel antibodies. To date, the company has manufactured over 50,000 antibodies against more than 20,000 human gene targets. They help customers optimize proteomic assays, accelerate life science research, improve reproducibility, and discover novel protein targets. ASB's head office is in San Diego, CA. They also have offices in Beijing and Tianjin China. For more information, please visit www.avivasysbio.com.
About GenWay Biotech
Since 1998, GenWay Biotech Incorporated has provided the research community with proteomic solutions and applications by offering a comprehensive catalog of products and services. To date, GenWay scientists have produced thousands of proteins and antibodies at their San Diego facility. The company strives to provide customized solutions to each project. GenWay's head office is in San Diego, CA as well. For more information, please visit www.genwaybio.com.
CONTACT: Matt Landry, 858-552-6979, firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/aviva-systems-biology-acquires-genway-biotech-300412060.html
SOURCE Aviva Systems Biology Corporation